Search

everythinglearnresearchcommunity

for

Search:↓

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

The new formulation greatly improved quercetin absorption in rats.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Lung and liver macrophages protect our tissues and their dysfunction can cause various diseases.

Machine learning can help find new ways to treat alopecia areata.

Vitamin C deficiency can persist in high-risk patients despite supplementation.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

Comprehensive information and trained nurses are crucial for a better scalp cooling experience during chemotherapy.

General practitioners in Qassim have satisfactory knowledge of alopecia areata but need more education to address gaps and misconceptions.

Genetic risk for hair loss can increase depression risk, but depression doesn't increase hair loss risk.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Customized dermatological treatments effectively address gaps in standard products, especially for complex cases.

Alopecia areata is becoming more common in Japan, with a need for better treatments, especially for severe and pediatric cases.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Severe menstrual issues in PCOS women signal higher risk for heart and metabolic problems.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Alopecia androgenética in women can lower self-esteem and cause mental health issues.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

AAG causes hair loss in many people, with limited treatments like finasteride, minoxidil, light therapy, and hair transplants.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.